📣 VC round data is live. Check it out!
- Public Comps
- Firefly Neuroscience
Firefly Neuroscience Valuation Multiples
Discover Firefly Neuroscience's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Substrate Artificial, ContextVision, Insig AI, Carelabs and more.
Firefly Neuroscience Overview
About Firefly Neuroscience
Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.
Founded
2022
HQ

Employees
14
Website
Sectors
Financials (FY)
EV
$27M
Valuation Multiples
Start free trialFirefly Neuroscience Financials
Firefly Neuroscience reported last fiscal year revenue of $1M and negative EBITDA of ($20M).
In the same fiscal year, Firefly Neuroscience generated $645K in gross profit, ($20M) in EBITDA losses, and had net loss of ($20M).
Firefly Neuroscience P&L
In the most recent fiscal year, Firefly Neuroscience reported revenue of $1M and EBITDA of ($20M).
Firefly Neuroscience is unprofitable as of last fiscal year, with gross margin of 56%, EBITDA margin of (1712%), and net margin of (1741%).
Financial data powered by Morningstar, Inc.
Firefly Neuroscience Stock Performance
Firefly Neuroscience has current market cap of $28M, and enterprise value of $27M.
Market Cap Evolution
Firefly Neuroscience's stock price is $1.78.
Firefly Neuroscience share price increased by 0.5% in the last 30 days, and decreased by 36.9% in the last year.
Firefly Neuroscience has an EPS (earnings per share) of $-1.28.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $27M | $28M | 4.1% | 0.5% | -23.2% | -36.9% | $-1.28 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFirefly Neuroscience Valuation Multiples
Firefly Neuroscience trades at 23.3x EV/Revenue multiple, and (1.4x) EV/EBITDA.
Firefly Neuroscience Financial Valuation Multiples
As of June 4, 2026, Firefly Neuroscience has market cap of $28M and EV of $27M.
Firefly Neuroscience has a P/E ratio of (1.4x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Firefly Neuroscience Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Firefly Neuroscience Margins & Growth Rates
In the most recent fiscal year, Firefly Neuroscience reported gross margin of 56%, EBITDA margin of (1712%), and net margin of (1741%).
Firefly Neuroscience Margins
Firefly Neuroscience Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Firefly Neuroscience Operational KPIs
Firefly Neuroscience's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.7M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Firefly Neuroscience Competitors
Firefly Neuroscience competitors include Substrate Artificial, ContextVision, Insig AI, Carelabs, Lighton, Avilen, Cambridge Cognition, Datrix, Doctor Care Anywhere and NextPlat.
Most Firefly Neuroscience public comparables operate across Healthcare Software, Vertical AI Applications, Artificial Intelligence, B2B SaaS, Vertical SaaS, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.4x | - | 2.2x | - | |||
| 1.6x | 1.6x | 8.7x | 8.7x | |||
| 39.7x | - | (3.5x) | - | |||
| 0.0x | - | 0.1x | - | |||
| 12.8x | 8.2x | (3.4x) | (4.2x) | |||
| 2.8x | 2.8x | 14.6x | - | |||
| 1.8x | 1.6x | (33.9x) | (106.4x) | |||
| 2.2x | 2.3x | 18.0x | 14.6x | |||
This data is available for Pro users. Sign up to see all Firefly Neuroscience competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Firefly Neuroscience
Firefly Neuroscience has acquired 1 company to date.
Last acquisition by Firefly Neuroscience was on May 6th 2025. Firefly Neuroscience acquired Evoke Neuroscience for $6M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Firefly Neuroscience
| Description | Evoke Neuroscience is a San Diego firm advancing brain training software for peak performance and recovery. Founded in 2009, its platforms target concussion management, elite athlete optimization, and cognitive aging through neurofeedback protocols validated in military and sports studies. |
| HQ Country | |
| HQ City | New York City, NY |
| Deal Date | 6 May 2025 |
| Valuation | $6M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Firefly Neuroscience acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Firefly Neuroscience
| When was Firefly Neuroscience founded? | Firefly Neuroscience was founded in 2022. |
| Where is Firefly Neuroscience headquartered? | Firefly Neuroscience is headquartered in United States. |
| How many employees does Firefly Neuroscience have? | As of today, Firefly Neuroscience has over 14 employees. |
| Who is the CEO of Firefly Neuroscience? | Firefly Neuroscience's CEO is Greg Lipschitz. |
| Is Firefly Neuroscience publicly listed? | Yes, Firefly Neuroscience is a public company listed on Nasdaq. |
| What is the stock symbol of Firefly Neuroscience? | Firefly Neuroscience trades under AIFF ticker. |
| When did Firefly Neuroscience go public? | Firefly Neuroscience went public in 2024. |
| Who are competitors of Firefly Neuroscience? | Firefly Neuroscience main competitors include Substrate Artificial, ContextVision, Insig AI, Carelabs, Lighton, Avilen, Cambridge Cognition, Datrix, Doctor Care Anywhere, NextPlat. |
| What is the current market cap of Firefly Neuroscience? | Firefly Neuroscience's current market cap is $28M. |
| What is the current revenue of Firefly Neuroscience? | Firefly Neuroscience's last fiscal year revenue is $1M. |
| What is the current EV/Revenue multiple of Firefly Neuroscience? | Current revenue multiple of Firefly Neuroscience is 23.3x. |
| Is Firefly Neuroscience profitable? | No, Firefly Neuroscience is not profitable. |
| How many companies Firefly Neuroscience has acquired to date? | As of June 2026, Firefly Neuroscience has acquired 1 company. |
| What was the largest acquisition by Firefly Neuroscience? | $6M acquisition of Evoke Neuroscience on 6th May 2025 was the largest M&A Firefly Neuroscience has done to date. |
| What companies Firefly Neuroscience acquired? | Firefly Neuroscience acquired Evoke Neuroscience. |
| In how many companies Firefly Neuroscience has invested to date? | Firefly Neuroscience hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Firefly Neuroscience
Lists including Firefly Neuroscience
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
